BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35394110)

  • 1. People with HIV have a higher risk of COVID-19 diagnosis but similar outcomes to the general population.
    Tang ME; Gaufin T; Anson R; Zhu W; Mathews WC; Cachay ER
    HIV Med; 2022 Nov; 23(10):1069-1077. PubMed ID: 35394110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 hospitalization outcomes in adults by HIV status; a nation-wide register-based study.
    Möller IK; Gisslén M; Wagner P; Sparén P; Carlander C
    HIV Med; 2023 Oct; 24(10):1045-1055. PubMed ID: 37286199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between post-acute sequelae of SARS-CoV-2, COVID-19 vaccination and HIV infection: a United States cohort study.
    Yendewa GA; Perez JA; Patil N; McComsey GA
    Front Immunol; 2024; 15():1297195. PubMed ID: 38318191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study.
    Nomah DK; Reyes-Urueña J; Díaz Y; Moreno S; Aceiton J; Bruguera A; Vivanco-Hidalgo RM; Llibre JM; Domingo P; Falcó V; Imaz A; Cortés C; Force L; Letang E; Vilaró I; Casabona J; Miro JM;
    Lancet HIV; 2021 Nov; 8(11):e701-e710. PubMed ID: 34655549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of Postvaccination Breakthrough COVID-19 Infections Among Adults With HIV in the United States.
    Coburn SB; Humes E; Lang R; Stewart C; Hogan BC; Gebo KA; Napravnik S; Edwards JK; Browne LE; Park LS; Justice AC; Gordon KS; Horberg MA; Certa JM; Watson E; Jefferson CR; Silverberg MJ; Skarbinski J; Leyden WA; Williams CF; Althoff KN;
    JAMA Netw Open; 2022 Jun; 5(6):e2215934. PubMed ID: 35671054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 Severity in People With HIV Compared With Those Without HIV.
    Nguyen VT; Nagavedu K; Morrison M; Chen T; Randall LM; Landazabal C; John B; Klompas M; Cocoros NM
    J Acquir Immune Defic Syndr; 2024 Apr; 95(5):479-485. PubMed ID: 38301641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 percent positivity and risk factors among people with HIV at an urban academic medical center.
    Friedman EE; Devlin SA; McNulty MC; Ridgway JP
    PLoS One; 2021; 16(7):e0254994. PubMed ID: 34288954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes following severe acute respiratory syndrome coronavirus 2 infection among individuals with and without HIV in Denmark.
    Rasmussen LD; Cowan S; Gerstoft J; Kronborg G; Johansen IS; Larsen CS; Weise L; Dalager-Pedersen M; Leth S; Nielsen LN; Lunding S; Omland LH; Obel N
    AIDS; 2023 Feb; 37(2):311-321. PubMed ID: 36129108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Major cardiovascular events after COVID-19 in people with HIV.
    Martín-Iguacel R; Moreno-Fornés S; Bruguera A; Aceitón J; Nomah DK; González-Cordón A; Domingo P; Curran A; Imaz A; Juanola DD; Peraire J; Borjabad B; Fernandez LA; Johansen IS; Miró JM; Casabona J; Llibre JM;
    Clin Microbiol Infect; 2024 May; 30(5):674-681. PubMed ID: 38342439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression Risk in People with HIV and COVID-19: Predictive Performance of Current Risk Scores.
    Vizcarra P; Cabello A; Moreno A; Vivancos MJ; López-Botet J; Zamarro B; Górgolas M; Casado JL
    AIDS Res Hum Retroviruses; 2021 Aug; 37(8):613-619. PubMed ID: 33913732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between comorbidities and coronavirus disease 2019 hospitalization among people with HIV differs by age.
    Moran CA; Oliver NT; Szabo B; Collins LF; Nguyen MLT; Shah NS; Moanna A; Colasanti JA; Cantos VD; Armstrong WS; Sheth AN; Ofotokun I; Kelley CF; Marconi VC; Lahiri CD
    AIDS; 2023 Jan; 37(1):71-81. PubMed ID: 36111530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 Outcomes Among People With HIV and COVID-19 in New York City.
    Braunstein SL; Wahnich A; Lazar R
    J Infect Dis; 2023 Nov; 228(11):1571-1582. PubMed ID: 37534822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 Testing and Positivity Among Persons With and Without HIV in 6 US Cohorts.
    Park LS; McGinnis KA; Gordon KS; Justice AC; Leyden W; Silverberg MJ; Skarbinski J; Jefferson C; Horberg M; Certa J; Napravnik S; Edwards JK; Westreich D; Bastarache L; Gangireddy S; Benning L; D'Souza G; Williams C; Althoff KN;
    J Acquir Immune Defic Syndr; 2022 Jul; 90(3):249-255. PubMed ID: 35195574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of Severe Illness After Postvaccination COVID-19 Breakthrough Among Adults With and Without HIV in the US.
    Lang R; Humes E; Coburn SB; Horberg MA; Fathi LF; Watson E; Jefferson CR; Park LS; Gordon KS; Akgün KM; Justice AC; Napravnik S; Edwards JK; Browne LE; Agil DM; Silverberg MJ; Skarbinski J; Leyden WA; Stewart C; Hogan BC; Gebo KA; Marconi VC; Williams CF; Althoff KN;
    JAMA Netw Open; 2022 Oct; 5(10):e2236397. PubMed ID: 36227594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brief Report: COVID-19 Testing, Characteristics, and Outcomes Among People Living With HIV in an Integrated Health System.
    Chang JJ; Bruxvoort K; Chen LH; Akhavan B; Rodriguez J; Hechter RC
    J Acquir Immune Defic Syndr; 2021 Sep; 88(1):1-5. PubMed ID: 34397741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk Factors for SARS-CoV-2 Infection and Severe Outcomes Among People With Human Immunodeficiency Virus: Cohort Study.
    Hanna JJ; Geresu LB; Diaz MI; Ho M; Casazza JA; Pickering MA; Lanier HD; Radunsky AP; Cooper LN; Saleh SN; Bedimo RJ; Most ZM; Perl TM; Lehmann CU; Turer RW; Chow JY; Medford RJ
    Open Forum Infect Dis; 2023 Aug; 10(8):ofad400. PubMed ID: 37577110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors Associated With Severity of COVID-19 Disease in a Multicenter Cohort of People With HIV in the United States, March-December 2020.
    Shapiro AE; Bender Ignacio RA; Whitney BM; Delaney JA; Nance RM; Bamford L; Wooten D; Keruly JC; Burkholder G; Napravnik S; Mayer KH; Webel AR; Kim HN; Van Rompaey SE; Christopoulos K; Jacobson J; Karris M; Smith D; Johnson MO; Willig A; Eron JJ; Hunt P; Moore RD; Saag MS; Mathews WC; Crane HM; Cachay ER; Kitahata MM;
    J Acquir Immune Defic Syndr; 2022 Aug; 90(4):369-376. PubMed ID: 35364600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronavirus Disease 2019 (COVID-19) Infection Among People With Human Immunodeficiency Virus in New York City: A Population-Level Analysis of Linked Surveillance Data.
    Braunstein SL; Lazar R; Wahnich A; Daskalakis DC; Blackstock OJ
    Clin Infect Dis; 2021 Jun; 72(12):e1021-e1029. PubMed ID: 33252620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asymptomatic SARS-CoV-2 Infection Is Common Among ART-Treated People With HIV.
    Overton ET; Weir IR; Zanni MV; Fischinger S; MacArthur RD; Aberg JA; Fitch KV; Frank M; Albrecht H; Goodenough E; Rhame FS; Fichtenbaum CJ; Bloomfield GS; Malvestutto C; Supparatpinyo K; McCallum S; Douglas PS; Alter G; Ribaudo H; Grinspoon SK
    J Acquir Immune Defic Syndr; 2022 Aug; 90(4):377-381. PubMed ID: 35413022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive concerns are a risk factor for mortality in people with HIV and coronavirus disease 2019.
    Wilcox DR; Rudmann EA; Ye E; Noori A; Magdamo C; Jain A; Alabsi H; Foy B; Triant VA; Robbins GK; Westover MB; Das S; Mukerji SS
    AIDS; 2023 Aug; 37(10):1565-1571. PubMed ID: 37195278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.